Abstract
Background: Since 2001 the International Olympic Committee-Medical Commission (IOC-MC) has required athletes using inhaled β2 agonists to provide clinical evidence of their asthmatic condition. The aim of this study was...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
